Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies"

JMIR Public Health Surveill. 2024 Mar 13:10:e54756. doi: 10.2196/54756.

Limin Wang^#^{1

2

3}, Shimeng Liu^{4

5}, Shan Jiang⁶, Chaofan Li^{1

2

3}, Liyong Lu^{1

2

3}, Yunhai Fang⁷, Shunping Li^{1

2

3}

¹ Centre for Health Management and Policy Research, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
² NHC Key Laboratory of Health Economics and Policy Research, Shandong University, Jinan, China.
³ Centre for Health Preference Research, Shandong University, Jinan, China.
⁴ School of Public Health, Fudan University, Shanghai, China.
⁵ NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.
⁶ Macquarie University Centre for the Health Economy, Macquarie Business School and Australian Institute of Health Innovation, Macquarie University, Sydney, Australia.
⁷ Shandong Hemophilia Treatment Center, Shandong Blood Center, Jinan, China.

^# Contributed equally.

No abstract available

Keywords: benefit-risk assessment; discrete choice experiment; hemophilia A; patient preference; prophylactic treatment.

MeSH terms